Sincere Co., LTD. (TYO:7782)
639.00
+14.00 (2.24%)
Jul 18, 2025, 3:30 PM JST
Sincere Co., LTD. Revenue
Sincere Co., LTD. had revenue of 1.56B JPY in the quarter ending March 31, 2025, with 2.43% growth. This brings the company's revenue in the last twelve months to 6.58B, up 11.46% year-over-year. In the year 2024, Sincere Co., LTD. had annual revenue of 6.54B with 9.70% growth.
Revenue (ttm)
6.58B
Revenue Growth
+11.46%
P/S Ratio
0.62
Revenue / Employee
119.56M
Employees
55
Market Cap
4.09B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.54B | 578.00M | 9.70% |
Dec 31, 2023 | 5.96B | 376.00M | 6.73% |
Dec 31, 2022 | 5.59B | 1.03B | 22.56% |
Dec 31, 2021 | 4.56B | 369.00M | 8.81% |
Dec 31, 2020 | 4.19B | -180.00M | -4.12% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Takeda Pharmaceutical Company | 4,581.55B |
Daiichi Sankyo Company | 1,886.26B |
HOYA Corporation | 866.03B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Shionogi & | 438.27B |